Enhance your knowledge with our comprehensive guide and curated study materials.
Includes:
✔ Structure of heme
✔ Biosynthesis (all steps, sites, enzymes, cofactors)
✔ Regulation
✔ Porphyrias (all types, features, lab findings)
Everything will be pointwise, exam-focused, with tables in your preferred list format.
Heme = protoporphyrin IX + ferrous iron (Fe²⁺).
Porphyrin ring = tetrapyrrole (four pyrrole rings linked by methenyl bridges).
Central Fe²⁺ binds:
O₂ (in Hb, Mb)
Electrons (in cytochromes)
Side chains on protoporphyrin IX:
4 methyl (–CH₃)
2 vinyl (–CH=CH₂)
2 propionate (–CH₂–CH₂–COO⁻)
Function: Essential component of hemoglobin, myoglobin, cytochromes, catalase, peroxidases.
Occurs in all nucleated cells, most active in:
Bone marrow (85%) → hemoglobin
Liver (15%) → cytochromes
Pathway takes place partly in mitochondria and partly in cytosol.
🔸 Step 1 – Rate-limiting step
Glycine + Succinyl-CoA → δ-ALA
Enzyme: ALA synthase
Cofactor: Pyridoxal phosphate (Vitamin B6)
Site: Mitochondria
🔸 Step 2
ALA → Porphobilinogen (PBG)
Enzyme: ALA dehydratase (PBG synthase)
Inhibited by lead (Pb)
Site: Cytosol
🔸 Step 3
4 PBG → Hydroxymethylbilane
Enzyme: PBG deaminase
Site: Cytosol
🔸 Step 4
Hydroxymethylbilane → Uroporphyrinogen III
Enzyme: Uroporphyrinogen III synthase
Site: Cytosol
🔸 Step 5
Uroporphyrinogen III → Coproporphyrinogen III
Enzyme: Uroporphyrinogen decarboxylase
Site: Cytosol
🔸 Step 6
Coproporphyrinogen III → Protoporphyrinogen IX
Enzyme: Coproporphyrinogen oxidase
Site: Mitochondria
🔸 Step 7
Protoporphyrinogen IX → Protoporphyrin IX
Enzyme: Protoporphyrinogen oxidase
Site: Mitochondria
🔸 Step 8 — Final Step
Protoporphyrin IX + Fe²⁺ → Heme
Enzyme: Ferrochelatase
Inhibited by lead (Pb)
Site: Mitochondria
In liver:
Inhibited by heme / hemin (end-product inhibition)
Upregulated by drugs that induce cytochrome P450 (barbiturates, griseofulvin, phenytoin).
In bone marrow:
Regulated primarily by iron availability.
ALA dehydratase
Ferrochelatase
→ ↑ ALA, ↑ Protoporphyrin
→ Anemia + neurologic symptoms
Occurs mostly in reticuloendothelial (RE) cells of spleen, liver, bone marrow.
Enzyme: Heme oxygenase
Releases Fe³⁺ and CO
Requires O₂ + NADPH
Enzyme: Biliverdin reductase
Unconjugated bilirubin is insoluble → binds to albumin.
Bilirubin + UDP-glucuronic acid
Enzyme: UDP-glucuronyltransferase
Forms bilirubin diglucuronide (water soluble)
Bilirubin → Urobilinogen
Urobilin (in urine) → yellow
Stercobilin (in stool) → brown
Porphyrias = inherited/acquired disorders of heme synthesis due to enzyme defects.
They cause accumulation of specific intermediates → neurovisceral or photosensitive symptoms.
Enzyme deficient: PBG deaminase
Accumulation: ALA, PBG
Features:
Severe abdominal pain
Neuropsychiatric symptoms
NO photosensitivity
Red wine-colored urine
Enzyme deficient: Uroporphyrinogen decarboxylase
Features:
Photosensitivity
Blisters on sun-exposed skin
Red-brown urine
Most common porphyria.
Enzyme deficient: Uroporphyrinogen III synthase
Severe photosensitivity
Red teeth (erythrodontia)
Enzyme deficient: Coproporphyrinogen oxidase
Mixed: abdominal pain + photosensitivity
Enzyme deficient: Protoporphyrinogen oxidase
Neurovisceral + photosensitivity
Porphyria – Enzyme Defect → Symptoms
AIP – PBG deaminase → abdominal pain, neuropathy, NO photosensitivity
PCT – Uroporphyrinogen decarboxylase → blistering photosensitivity
CEP – Uroporphyrinogen III synthase → severe photosensitivity, red teeth
HCP – Coproporphyrinogen oxidase → pain + photosensitivity
VP – Protoporphyrinogen oxidase → mixed symptoms
Lead inhibits:
ALA dehydratase
Ferrochelatase
→ ↑ ALA
→ ↑ Protoporphyrin
→ Microcytic anemia
Heme is a porphyrin ring with iron (Fe²⁺) at the center.
The ring is called protoporphyrin IX.
It consists of four pyrrole rings (A, B, C, D) linked via methene bridges.
Side chains on pyrrole rings include methyl, vinyl, and propionate groups.
The central Fe²⁺ binds with:
4 nitrogens of the ring
1 binding site for globin
1 site for O₂, CO, NO or other ligands (“sixth position”).
Fe must be in ferrous form (Fe²⁺) to bind oxygen (Fe³⁺ cannot bind O₂).
Heme is found in hemoglobin, myoglobin, cytochromes, catalase, and peroxidases.
Occurs in all tissues, mainly:
85% in bone marrow (RBC formation)
15% in liver (cytochrome production)
Mitochondria → Cytosol → Mitochondria
Enzyme: ALA synthase (ALAS)
Cofactor: Pyridoxal phosphate (Vitamin B₆)
Rate-limiting step
Occurs in mitochondria
Inhibited by heme (negative feedback)
Induced by many drugs in liver that increase cytochrome P450 demand → ALAS upregulation
Enzyme: ALA dehydratase (ALA-D)
Location: Cytosol
Lead inhibits ALA dehydratase, causing ALA accumulation.
Enzyme: PBG deaminase (HMB synthase)
Deficiency → Acute Intermittent Porphyria
Enzyme: Uroporphyrinogen III synthase
If enzyme deficient → non-physiological type I porphyrins form (photosensitive).
Enzyme: Uroporphyrinogen decarboxylase
Defect → Porphyria Cutanea Tarda (PCT)
Most common porphyria
Photosensitivity
Enzyme: Coproporphyrinogen oxidase
Occurs in mitochondria (re-entry).
Enzyme: Protoporphyrinogen oxidase
Enzyme: Ferrochelatase
Inhibited by lead, causing accumulation of protoporphyrin IX
Final step in mitochondria
Key regulatory enzyme: ALA synthase
Inhibited by heme/hemin
Liver ALAS induced by drugs: barbiturates, alcohol, antiepileptics
RBC heme synthesis depends on erythropoietin & iron availability
Inhibits:
ALA dehydratase
Ferrochelatase
Effects:
↑ ALA
↑ Protoporphyrin
↓ Heme synthesis
Microcytic hypochromic anemia
Porphyrias = defects in heme biosynthetic enzymes → accumulation of intermediates.
Classified into:
(Usually neurovisceral symptoms)
(Usually photosensitivity)
Defect: PBG deaminase
Accumulation: ALA, PBG
Features:
Acute abdominal pain
Neuropsychiatric symptoms
Red-wine urine darkening on standing
No photosensitivity
Triggered by drugs, starvation, alcohol
Treatment: hemin (inhibits ALAS)
Defect: Uroporphyrinogen decarboxylase (UROD)
Accumulation: Uroporphyrin
Features:
Photosensitivity
Blistering skin lesions
Hyperpigmentation
Elevated liver enzymes
Associated with alcohol, estrogens, HCV infection
Defect: Uroporphyrinogen III synthase
Accumulation: Type I porphyrins
Features:
Severe photosensitivity
Red urine
Hemolytic anemia
Erythrodontia (red-brown teeth that fluoresce)
Defect: Coproporphyrinogen oxidase
Features:
Neurovisceral attacks
Variable photosensitivity
Defect: Protoporphyrinogen oxidase
Features:
Neurovisceral symptoms
Photosensitivity
Skin blistering
“Mixed” presentation
Defect: Ferrochelatase
Accumulation: Protoporphyrin IX
Features:
Photosensitivity
Burning sensation in sunlight
Mild liver dysfunction possible
AIP: Abdominal pain + neuro symptoms; no photosensitivity
PCT: Photosensitivity + blistering; most common
CEP: Childhood onset, severe photosensitivity, red teeth
EPP: Mild photosensitivity, protoporphyrin buildup
Variegate/HCP: Neuro + skin symptoms both present
Mainly in reticuloendothelial system (RES)
– Spleen
– Liver
– Bone marrow
Occurs when RBCs reach end of lifespan (~120 days) or during hemolysis.
Enzyme: Heme oxygenase
Requires: O₂ + NADPH
Iron (Fe²⁺ → Fe³⁺) released and reused
Carbon monoxide (CO) also produced
Enzyme: Biliverdin reductase
Produces unconjugated bilirubin (indirect)
Water-insoluble → transported bound to albumin
Unconjugated (“indirect”) bilirubin is lipid-soluble
Strongly bound to albumin in blood
Cannot be excreted in urine
Enters hepatocytes by facilitated transport
Enzyme: UDP-glucuronyl transferase (UGT1A1)
Water-soluble form = conjugated bilirubin (direct)
Secreted into bile canaliculi → bile → intestine
By gut bacteria
Some absorbed → liver (enterohepatic circulation)
Some filtered by kidneys → urobilin (yellow)
Most converted in colon → stercobilin (brown)
This gives stool its brown color and urine its yellow color.
Direct bilirubin
Water-soluble
Conjugated
Can appear in urine
Indirect bilirubin
Water-insoluble
Unconjugated
Albumin-bound
Cannot appear in urine
Total bilirubin = Direct + Indirect
“Shunt bilirubin” refers to bilirubin formed from heme precursors other than hemoglobin before the RBC matures.
Destruction of ineffective erythroid precursors in bone marrow
Called intramedullary hemolysis
Thalassemia major
Megaloblastic anemia
Sideroblastic anemia
Myelodysplastic syndromes
Elevated unconjugated bilirubin
Normal or mildly reduced hemoglobin
Reticulocyte count may not rise proportionately
This concept explains jaundice in severe ineffective erythropoiesis without peripheral hemolysis.
Classified into:
↑ RBC destruction
↑ Unconjugated bilirubin
No bilirubin in urine
↑ Urobilinogen
Hemolytic anemia
Thalassemia
G6PD deficiency
Shunt bilirubin (ineffective erythropoiesis)
Due to impaired uptake, conjugation, or excretion.
Drugs (rifampicin)
Sepsis
Gilbert syndrome (mild ↓ UGT1A1)
Crigler–Najjar type I (no UGT; severe)
Crigler–Najjar type II (partial deficiency)
Dubin–Johnson syndrome (defective canalicular transport)
Rotor syndrome (defective hepatic storage)
↑ Conjugated bilirubin
Clay-colored stools (↓ stercobilin)
Dark urine (↑ conjugated bilirubin)
Pruritus (bile salts)
Gallstones
Carcinoma of head of pancreas
Cholangiocarcinoma
Strictures
Primary sclerosing cholangitis
Hemolysis
Shunt bilirubin
Gilbert
Crigler–Najjar
Neonatal jaundice
Obstruction
Dubin–Johnson
Rotor
Hepatitis/cholestasis
These are inherited defects in bilirubin conjugation or excretion.
Mild ↓ UGT1A1 activity
Slight ↑ unconjugated bilirubin (usually <3 mg/dL)
Triggered by fasting, stress, infection
Completely benign
Complete absence of UGT1A1
Very high unconjugated bilirubin (>20 mg/dL)
Fatal in infancy due to kernicterus
No response to phenobarbital
Partial deficiency of UGT1A1
Moderate unconjugated bilirubin
Responds to phenobarbital (induces enzyme)
Defect in canalicular transport protein (MRP2)
↑ conjugated bilirubin
Dark, black pigmented liver
Benign
Defect in hepatic storage/uptake of conjugated bilirubin
↑ conjugated bilirubin
Liver is not pigmented (unlike Dubin–Johnson)
Benign
| Disorder | Conjugation | Excretion | Type |
|---|---|---|---|
| Gilbert | ↓ | Normal | Unconjugated |
| Crigler–Najjar I | Absent | Normal | Unconjugated |
| Crigler–Najjar II | ↓↓ | Normal | Unconjugated |
| Dubin–Johnson | Normal | Defective | Conjugated |
| Rotor | Normal | Defective uptake/storage | Conjugated |
Caused by increased RBC breakdown → overproduction of bilirubin.
↑ Unconjugated bilirubin
Normal liver function
No bilirubin in urine (unconjugated is water-insoluble)
↑ Urobilinogen (more bilirubin entering gut)
Dark stools
Anemia + reticulocytosis
Hemolytic anemia (autoimmune, hereditary spherocytosis)
G6PD deficiency
Sickle cell disease
Thalassemia
Malaria
Shunt bilirubin from ineffective erythropoiesis
Due to damage to hepatocytes → impaired uptake, conjugation, and excretion.
↑ Both unconjugated & conjugated bilirubin
↑ AST/ALT
Bilirubin in urine (conjugated)
Variable stool color
↑ or ↓ urobilinogen
Jaundice + hepatomegaly + systemic symptoms
Viral hepatitis
Alcoholic hepatitis
Drug-induced liver injury
NAFLD
Cirrhosis
Wilson disease, hemochromatosis
Due to bile flow blockage.
↑ Conjugated bilirubin
Very dark urine (conjugated bilirubin excreted in urine)
Clay-colored stool (↓ stercobilin)
Severe itching (bile salts in skin)
↑ ALP & GGT
↓ urobilinogen
Gallstones
Carcinoma head of pancreas
Cholangiocarcinoma
Primary sclerosing cholangitis
Biliary atresia
Strictures
Here is the cleanest differentiation, perfect for exams:
Bilirubin: Unconjugated ↑
Urine bilirubin: Absent
Urine urobilinogen: ↑
Stool color: Dark
Enzymes: Normal
Example: G6PD deficiency
Bilirubin: Both ↑
Urine bilirubin: Present
Urine urobilinogen: Variable
Stool: Normal or pale
Enzymes: AST/ALT ↑
Example: Viral hepatitis
Bilirubin: Conjugated ↑
Urine bilirubin: Present (very high)
Urine urobilinogen: ↓
Stool: Clay-colored
Enzymes: ALP/GGT ↑↑
Example: Gallstones, pancreatic cancer
Unconjugated ↑: hemolysis, Gilbert, Crigler–Najjar
Conjugated ↑: obstruction, Dubin–Johnson, Rotor
Urine dark: conjugated bilirubin
Clay stool: obstructive jaundice
High urobilinogen: hemolysis
Pruritus: cholestasis
Heme = protoporphyrin IX + Fe²⁺ at center.
Consists of four pyrrole rings linked by methene bridges.
Fe²⁺ must be in ferrous form to bind oxygen.
Found in hemoglobin, myoglobin, cytochromes, catalase, peroxidases.
Occurs in mitochondria → cytosol → mitochondria.
Major sites: bone marrow (85%), liver (15%).
ALA synthase is the rate-limiting step.
Requires Vitamin B6 (PLP).
Inhibited by heme (feedback); induced by drugs that increase cytochrome P450.
Lead inhibits ALA dehydratase and ferrochelatase.
Leads to ↑ ALA, ↑ protoporphyrin, ↓ heme synthesis.
Glycine + Succinyl CoA → ALA (ALAS)
2 ALA → PBG (ALA dehydratase)
4 PBG → Hydroxymethylbilane (PBG deaminase)
Uroporphyrinogen III → Coproporphyrinogen
Coproporphyrinogen → Protoporphyrin
Protoporphyrin + Fe²⁺ → Heme (ferrochelatase)
Due to enzyme defects in heme pathway → accumulation of intermediates.
Hepatic porphyrias → neurovisceral symptoms.
Erythropoietic porphyrias → photosensitivity.
Acute Intermittent Porphyria (AIP):
↓ PBG deaminase
↑ ALA & PBG
Abdominal pain + neuro symptoms
No photosensitivity
Porphyria Cutanea Tarda (PCT):
↓ Uroporphyrinogen decarboxylase
Photosensitivity, blistering
Most common porphyria
Congenital Erythropoietic Porphyria (CEP):
↓ Uroporphyrinogen III synthase
Severe photosensitivity, red urine, erythrodontia
Erythropoietic Protoporphyria (EPP):
↓ Ferrochelatase
Mild photosensitivity
Occurs in RES (spleen/liver/bone marrow).
Heme → biliverdin (heme oxygenase).
Biliverdin → bilirubin (biliverdin reductase).
Unconjugated bilirubin → albumin-bound → liver.
Conjugated bilirubin formed by UGT1A1.
Excreted into bile → intestine → urobilinogen →
Urobilin (urine)
Stercobilin (stool)
Bilirubin produced from ineffective erythropoiesis (intramedullary destruction).
Causes isolated unconjugated hyperbilirubinemia without hemolysis.
Unconjugated (indirect):
Albumin-bound
Lipid-soluble
Cannot appear in urine
Conjugated (direct):
Water-soluble
Appears in urine
Indicates intrahepatic or obstructive pathology
Gilbert: Mild ↓ UGT
Crigler–Najjar I: Absent UGT (fatal)
Crigler–Najjar II: Marked ↓ UGT (responds to phenobarbital)
Dubin–Johnson: MRP2 defect, black liver
Rotor: Defect in hepatic uptake/storage, normal-colored liver
↑ RBC destruction → ↑ unconjugated bilirubin
No bilirubin in urine
↑ urobilinogen
Normal liver enzymes
Seen in hemolysis, thalassemia, G6PD deficiency, shunt bilirubin.
Hepatocyte damage → impaired uptake, conjugation, excretion
↑ both conjugated & unconjugated bilirubin
↑ AST/ALT
Urine bilirubin present
Variable stool/urobilinogen
Blocked bile flow
↑ conjugated bilirubin
Clay-colored stool
Dark urine
Pruritus (bile salts)
↑ ALP & GGT
↓ urobilinogen
| Feature | Hemolytic | Hepatocellular | Obstructive |
|---|---|---|---|
| Type of bilirubin | Unconj ↑ | Both ↑ | Conj ↑ |
| Urine bilirubin | Absent | Present | Present (high) |
| Urine urobilinogen | ↑ | Variable | ↓ |
| Stool color | Dark | Normal/light | Pale (clay) |
| Enzymes | Normal | AST/ALT ↑ | ALP/GGT ↑ |
ALA synthase = rate-limiting; inhibited by heme.
Lead inhibits ALA dehydratase & ferrochelatase.
AIP = neuro symptoms, no photosensitivity.
PCT = most common porphyria, blistering.
Unconjugated ↑: hemolysis, Gilbert, Crigler–Najjar.
Conjugated ↑: obstruction, Dubin–Johnson, Rotor.
Clay stool + dark urine = obstructive jaundice.
Urobilinogen ↑ = hemolysis.
A. Fe³⁺
B. Mg²⁺
C. Cu²⁺
D. Fe²⁺
Answer: D
A. Ferrochelatase
B. ALA dehydratase
C. PBG deaminase
D. ALA synthase
Answer: D
A. Vitamin C
B. Vitamin K
C. Vitamin B6 (PLP)
D. Vitamin A
Answer: C
A. ALA synthase & PBG deaminase
B. ALA dehydratase & ferrochelatase
C. Uroporphyrinogen decarboxylase & coproporphyrinogen oxidase
D. Heme oxygenase & biliverdin reductase
Answer: B
A. PCT
B. CEP
C. Variegate porphyria
D. Acute Intermittent Porphyria
Answer: D
A. PBG deaminase
B. ALA synthase
C. Uroporphyrinogen decarboxylase
D. Ferrochelatase
Answer: C
A. AIP
B. CEP
C. PCT
D. Crigler–Najjar
Answer: C
A. Biliverdin reductase
B. UDP-glucuronyl transferase
C. Heme oxygenase
D. Ferrochelatase
Answer: C
A. Hemoglobin
B. Ceruloplasmin
C. Transferrin
D. Albumin
Answer: D
A. ATP
B. Vitamin B6
C. CoA
D. UDP-glucuronic acid
Answer: D
A. Unconjugated
B. Conjugated
C. Delta bilirubin
D. Shunt bilirubin
Answer: B
A. Renal tubules
B. Blood plasma
C. Bile canaliculi
D. Portal vein
Answer: C
A. Urobilin
B. Stercobilin
C. Biliverdin
D. Porphobilinogen
Answer: B
A. Gilbert syndrome
B. PCT
C. Crigler–Najjar type I
D. Dubin–Johnson syndrome
Answer: C
A. Unconjugated hyperbilirubinemia
B. Conjugated hyperbilirubinemia + dark pigmented liver
C. Enzyme destruction of UGT
D. Kernicterus
Answer: B
A. AIP
B. Gilbert
C. Dubin–Johnson
D. Rotor syndrome
Answer: D
A. ↑ Conjugated bilirubin
B. ↑ Unconjugated bilirubin
C. ↑ ALP
D. Clay-colored stool
Answer: B
A. Obstructive
B. Hepatocellular
C. Hemolytic
D. Congenital conjugated jaundice
Answer: C
A. Hemolysis
B. Hepatitis
C. Obstructive jaundice
D. Gilbert syndrome
Answer: C
A. Absent
B. Normal
C. Markedly elevated
D. Increased urobilinogen
Answer: C
A. AST
B. ALT
C. LDH
D. ALP
Answer: D
A. Obstruction
B. Hemolysis
C. Hepatocellular jaundice
D. Gilbert syndrome
Answer: C
A. Reticulocytes in spleen
B. Mature RBCs
C. Ineffective erythroid precursors in bone marrow
D. Kupffer cells
Answer: C
A. PCT
B. AIP
C. CEP (Günther disease)
D. EPP
Answer: C
A. ALA synthase
B. PBG deaminase
C. Ferrochelatase
D. Heme oxygenase
Answer: B
Diagnosis: Acute Intermittent Porphyria
Mechanism: ↓ PBG deaminase → ↑ ALA & PBG → neurotoxicity
Trigger: Drugs inducing ALA synthase (cytochrome P450 inducers)
Diagnosis: Porphyria Cutanea Tarda
Mechanism: ↓ Uroporphyrinogen decarboxylase → photosensitivity
Diagnosis: Congenital Erythropoietic Porphyria (CEP)
Mechanism: ↓ Uroporphyrinogen III synthase → Type I porphyrins accumulate
Diagnosis: Erythropoietic Protoporphyria
Mechanism: ↓ Ferrochelatase → ↑ Protoporphyrin IX → photosensitivity
Diagnosis: Lead poisoning
Mechanism: Lead inhibits ALA dehydratase & ferrochelatase → ↓ heme synthesis
Diagnosis: Crigler–Najjar Syndrome Type I
Mechanism: Complete absence of UGT1A1 → severe unconjugated bilirubin
Diagnosis: Gilbert Syndrome
Mechanism: Mild ↓ UGT1A1 activity
Diagnosis: Crigler–Najjar Syndrome Type II
Mechanism: Partial UGT deficiency
Diagnosis: Dubin–Johnson Syndrome
Mechanism: Defective canalicular excretion pump (MRP2)
Diagnosis: Rotor Syndrome
Mechanism: Defective uptake/storage of conjugated bilirubin
Diagnosis: Hemolytic jaundice
Mechanism: RBC destruction → ↑ heme breakdown → ↑ unconjugated bilirubin
Diagnosis: Hepatocellular jaundice
Mechanism: Impaired uptake, conjugation, and excretion
Diagnosis: Obstructive jaundice
Mechanism: Blocked bile flow → ↑ conjugated bilirubin
Diagnosis: Shunt bilirubin
Mechanism: Ineffective erythropoiesis → intramedullary destruction → ↑ unconjugated bilirubin
Diagnosis: Reperfusion injury
Mechanism: Sudden oxygen → massive ROS → further injury, contracture bands
Diagnosis: Hemolytic jaundice
Mechanism: High bilirubin load → more urobilinogen
Diagnosis: Extrahepatic biliary obstruction
Mechanism: No bilirubin enters intestine → ↓ stercobilin
Diagnosis: Neonatal physiological jaundice
Mechanism: Low UGT activity at birth
Diagnosis: Hepatocellular jaundice from alcoholic hepatitis/cirrhosis
Mechanism: Hepatocyte dysfunction
Diagnosis: Mild hemolysis
Mechanism: Excess RBC destruction with intact liver function
Heme is protoporphyrin IX with Fe²⁺ at its center.
Because only Fe²⁺ can bind oxygen.
Partly in mitochondria and partly in cytosol.
ALA synthase.
Vitamin B6 (pyridoxal phosphate).
ALA synthase (feedback inhibition).
ALA dehydratase and ferrochelatase.
Acute Intermittent Porphyria (AIP).
Accumulation of ALA & PBG causes neuronal dysfunction.
Porphyria Cutanea Tarda (PCT).
Uroporphyrinogen decarboxylase.
Congenital Erythropoietic Porphyria (CEP).
Insertion of Fe²⁺ into protoporphyrin IX by ferrochelatase.
In the reticuloendothelial system (RES)—mainly spleen.
Heme oxygenase.
Biliverdin reductase.
Unconjugated (indirect) bilirubin.
Conjugated bilirubin.
UDP-glucuronyl transferase (UGT1A1).
Converted to urobilinogen by gut bacteria.
Urobilin.
Stercobilin.
Unconjugated bilirubin formed from ineffective erythropoiesis (intramedullary destruction).
Crigler–Najjar Syndrome Type I.
Gilbert syndrome.
Dubin–Johnson syndrome.
Rotor syndrome.
Unconjugated hyperbilirubinemia with no bilirubin in urine.
Clay-colored stools, dark urine, and pruritus.
Obstructive (post-hepatic) jaundice.
Because hepatocyte uptake, conjugation, and excretion are impaired.
Hemolytic jaundice.
Obstructive jaundice.
Lack of bilirubin reaching the intestine → no stercobilin.
Excess conjugated bilirubin excreted by kidneys.
Induces UGT1A1, lowering bilirubin.
It is a byproduct of heme oxygenase activity.
Fe²⁺.
Conjugated bilirubin (due to impaired excretion).
ALP and GGT levels (high in obstruction).
Get the full PDF version of this chapter.